Cocoon Biotech

About:

Cocoon brings a healthy productive life to patients worldwide initially through treatments for arthritis.

Website: https://cocoonbiotech.com/

Top Investors: MassChallenge

Description:

Cocoon Biotech’s platform technology is a biocompatible silk protein that can be injected into joints to provide effective long lasting pain relief and potentially delay the progression of disease. This platform will leverage several unique properties of the silk protein fibroin, including strength, lubrication, and biocompatibility. Their mission is to use this technology to significantly improve the treatment of osteoarthritis and other degenerative joint disorders. The osteoarthritis treatment gap alone is currently quite large and new approaches that address both symptoms and disease progression are an urgent need.

Total Funding Amount:

$5.75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)cocoonbiotech.com

Founders:

Ailis Tweed-Kent

Number of Employees:

1-10

Last Funding Date:

2021-12-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai